Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Lucira Health has raised $80.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2022.
Lucira Health's investors include Y Combinator, Eclipse, National Science Foundation, DCVC, Hercules Capital.
Lucira Health is headquartered in Emeryville, United States.
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Lucira Health is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lucira Health — Funding & Investors." VCBacked, February 4, 2022, https://www.vcbacked.co/company/lucira-health. Accessed August 6, 2026.
VCBacked. (2022). Lucira Health — Funding & Investors. Retrieved August 6, 2026, from https://www.vcbacked.co/company/lucira-health
{{cite web |title=Lucira Health — Funding & Investors |url=https://www.vcbacked.co/company/lucira-health |website=VCBacked |access-date=August 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated